New device for dialysis access shows promise in 142 patients

NCT ID NCT04484220

Completed Disease control Sponsor: Medtronic Endovascular Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well the Ellipsys Vascular Access System works for creating arteriovenous (AV) fistulas in people with end-stage kidney disease who need dialysis. A total of 142 patients were followed for 12 months to see how long the access stayed open and how safe the procedure was. The goal was to provide a reliable way to connect an artery and vein for easier dialysis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AV FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease congenital arteriovenous fistula end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AV FISTULA FISTULAS ARTERIOVENOUS KIDNEY DISEASE, END-STAGE RENAL DISEASE, END STAGE

Contacts and locations

Locations

Azura Vascular Care, Jacksonville

Jacksonville, Florida, 32218, United States
Coastal Vascular and Interventional, PLLC

Pensacola, Florida, 32504, United States
Nephrology Associates Access Center

Riverside, California, 92501, United States
Nephrology Kidney Disease Hypertension Center

Las Vegas, Nevada, 89128, United States
Richmond Vascular Center

North Chesterfield, Virginia, 23236, United States
Rush University Medical Center

Chicago, Illinois, 60607, United States
STAR Vascular Access Center

San Antonio, Texas, 78207, United States
San Antonio Kidney Disease Center

San Antonio, Texas, 78216, United States
Staten Island Hospital

Staten Island, New York, 10305, United States
The Vascular Care Group

Hyannis, Massachusetts, 022601, United States
University of Pittsburg Medical Center

Pittsburgh, Pennsylvania, 15213, United States
Yale University

New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.